Quick Answer
Pasithea Therapeutics Corp. reported Total Assets of $60.24 million for fiscal year 2025.
Pasithea Therapeutics Corp. Total Assets — Annual History
| Fiscal Year | Total Assets | YoY Change |
|---|---|---|
| 2025 | $60.24M | +275.0% |
| 2024 | $16.06M | -38.5% |
| 2023 | $26.12M | -42.2% |
| 2022 | $45.18M | -15.3% |
| 2021 | $53.32M | +21403.9% |
| 2020 | $248.0K | — |
Quarterly Total Assets
| Quarter Ending | Total Assets | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $13.63M | -26.9% | -19.9% |
| June 30, 2025 | $17.01M | -3.7% | +16.0% |
| March 31, 2025 | $14.66M | -34.6% | -8.8% |
| December 31, 2024 | $16.06M | -38.5% | -13.8% |
| September 30, 2024 | $18.64M | -39.2% | +5.5% |
| June 30, 2024 | $17.66M | -53.7% | -21.2% |
| March 31, 2024 | $22.41M | -46.7% | -14.2% |
| December 31, 2023 | $26.12M | -42.2% | -14.8% |
- Pasithea Therapeutics Corp. showed an increase of +275.0% in Total Assets compared to the prior fiscal year.
- Over the 2020–2025 period, Pasithea Therapeutics Corp.’s total assets has grown by 24194.5% (from $248.0 thousand to $60.24 million).
- The most recent figure is from Pasithea Therapeutics Corp.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 30, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: